Pharmobedient Cnsltg Company Profile
✉ Email this page to a colleague
What is the competitive landscape for PHARMOBEDIENT CNSLTG
PHARMOBEDIENT CNSLTG has fifteen approved drugs.
Summary for Pharmobedient Cnsltg
| US Patents: | 0 |
| Tradenames: | 15 |
| Ingredients: | 15 |
| NDAs: | 15 |
Drugs and US Patents for Pharmobedient Cnsltg
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pharmobedient Cnsltg | DEXAMETHASONE | dexamethasone | ELIXIR;ORAL | 088254-001 | Jul 27, 1983 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Pharmobedient Cnsltg | CHOLESTYRAMINE LIGHT | cholestyramine | POWDER;ORAL | 209599-002 | Nov 12, 2020 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Pharmobedient Cnsltg | CIMETIDINE HYDROCHLORIDE | cimetidine hydrochloride | SOLUTION;ORAL | 074757-001 | Oct 17, 1997 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
